origanum dictamnus l
Botanicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2020 (NCT04705753)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04874857 | N/A | Nov 25, 2020 | Erciyes University |
| NCT04705753 | Phase 2/Phase 3 (Phase 3) | Apr 1, 2020 | Olvos Science SA, University of Crete, Vifor Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Erciyes University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Olvos Science SA | For profit | 1 | 0 | 1 | 2020 |
| University of Crete | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Vifor Inc. | For profit | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1